![[🔔 📣 Call for pharmaceutical companies to join in the CDDF Diversity Initiative]](https://hai.craftedflow.dev/wp-content/uploads/2024/09/Copy-of-Copy-of-Copy-of-Dark-Purple-and-Blue-Texture-Blur-Circle-Business-Marketing-Presentation-1080x675.jpg)
ACT EU: Stakeholder Presentation on Critical Use-Cases at MSP Advisory Group Meeting (4 July 2024)
On 4 July 2024, CDDF participated in a stakeholder presentation focused on critical use-cases at Multi-Stakeholder Platform (MSP) Advisory Group meeting. The session aimed to identify and discuss real-world challenges faced by stakeholder groups within the European...![[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]](https://hai.craftedflow.dev/wp-content/uploads/2024/07/Capture-4-1080x675.jpg)
[🔔 📢 Key Takeaways from the CDDF Webinar on “Bayesian Approaches in Drug Development”]
The Cancer Drug Development Forum (CDDF) held a live webinar on Bayesian Approaches in Drug Development on 11 July 2024. In this webinar, Rob Hemmings (Consilium) gave an insightful talk followed by a Q&A discussion moderated by Axel Glasmacher (CDDF) and Eva...
🔔 📢 NEW PUBLICATION: Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action (Lawler et al., 2024)
The Cancer Drug Development Forum (CDDF) is delighted to announce that a white paper, “Empowering Effective Biomarker-Driven Precision Oncology: A Call to Action” has been published in European Journal of Cancer (Vol 209, September 2024). This paper has been developed...